Open access · OA
via OpenAlex
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
René R. Sevag Packard, Peter Libby
Clinical Chemistry · 2007 · ▲ 932 citations
Abstract
Recent investigations of atherosclerosis have focused on inflammation, providing new insight into mechanisms of disease. Inflammatory cytokines involved in vascular inflammation stimulate the generation of endothelial adhesion molecules, proteases, and other mediators, which may enter the circulation in soluble form. These primary cytokines also induce production of the messenger cytokine interleukin-6, which stimulates the liver to increase production of acute-phase reactants such as C-reactive protein. In addition, platelets and adipose tissue can generate inflammatory mediators relevant to atherothrombosis. Despite the irreplaceable utility of plasma lipid profiles in assessment of atherosclerotic risk, these profiles provide an incomplete picture. Indeed, many cardiovascular events occur in individuals with plasma cholesterol concentrations below the National Cholesterol Education Program thresholds of 200 mg/dL for total cholesterol and 130 mg/dL for low-density lipoprotein (LDL) cholesterol. The concept of the involvement of inflammation in atherosclerosis has spurred the discovery and adoption of inflammatory biomarkers for cardiovascular risk prediction. C-reactive protein is currently the best validated inflammatory biomarker; in addition, soluble CD40 ligand, adiponectin, interleukin 18, and matrix metalloproteinase 9 may provide additional information for cardiovascular risk stratification and prediction. This review retraces the biology of atherothrombosis and the evidence supporting the role of inflammatory biomarkers in predicting primary cardiovascular events in this biologic context.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1373/clinchem.2007.097360
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Packard, R.R.S., & Libby, P. (2007). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. <em>Clinical Chemistry</em>. https://doi.org/10.1373/clinchem.2007.097360
Vancouver
Packard RRS, Libby P. Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clinical Chemistry. 2007. doi:10.1373/clinchem.2007.097360.
BibTeX
@article{ren2007Inflam,
title = {Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction},
author = {René R. Sevag Packard and Peter Libby},
journal = {Clinical Chemistry},
year = {2007},
doi = {10.1373/clinchem.2007.097360},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2025
Open access · CC-BY
Senescent Polarization of Macrophages and Inflammatory Biomarkers in Cardiovascular Disease
Frontiers in Immunology 2020
Open access · CC-BY
Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis
BMC Women s Health 2025
Open access · CC-BY
Increased plasma lipopolysaccharide-binding protein and altered inflammatory mediators reveal a pro-inflammatory state in overweight women
Cardiology News Opinions Training 2025
Open access · CC-BY
Association of additional cardiovascular risk factors with elevated arterial stiffness in young and middle-aged individuals
International Heart Journal 2016
Open access · OA
Inflammatory Biomarkers and Atherosclerosis
International Journal of Cardiovascular Sciences 2020
Open access · CC-BY